What is the current Global Neuropathic Pain Market size?

The Global Neuropathic Pain Market is projected to register a CAGR of 5.5% during the forecast period (2024-2029) Read More

Who are the key players in Global Neuropathic Pain Market?

Grünenthal, Mallinckrodt Pharmaceuticals, Pfizer, Inc., Novartis AG and Teva Pharmaceutical Industries Ltd. are the major companies operating in the Global Neuropathic Pain Market. Read More

Which is the fastest growing region in Global Neuropathic Pain Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Neuropathic Pain Market?

In 2024, the North America accounts for the largest market share in Global Neuropathic Pain Market. Read More

What years does this Global Neuropathic Pain Market cover?

The report covers the Global Neuropathic Pain Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Neuropathic Pain Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Neuropathic Pain Market - Size, Forecast & Growth

Neuropathic Pain Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Neuropathic Pain Therapeutics Market Forecast and it is Segmented by Indication (Diabetic Neuropathy, Spinal Stenosis, Chemotherapy-induced Peripheral Neuropathy, and Others), Drug Class (Tricyclic Antidepressants, Opioids, Capsaicin Cream, Steroids, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The Values are Provided in Terms of USD Million for above segments

Neuropathic Pain Industry Overview

The neuropathic pain market is moderately competitive and consists of a few major players. Companies like Grünenthal, Mallinckrodt Pharmaceuticals, GlaxoSmithKline Plc, J Pfizer, Inc., Cipla, Inc., Glenmark, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, among others, hold a substantial market share in the market.